Ann: Notice of Meeting of Stockholders on 10 April 2024, page-16

First 16 Last

Share
Profile

Follow
BalkanBroker

1,366 Posts.

280

28/03/24

07:47

Post #: 73095020
Share

Originally posted by UberTrader: ↑

Several recent actions by UBI's management raise concerns for shareholders.

Capital Raise Timing: The timing of the capital raise announcement relative to FDA approval and the CEO's exercise of stock options merits clarification.

Discounted Share Issuance: The significant discount offered to institutional investors during the capital raise following FDA approval warrants a full explanation. Shareholders deserve to understand the rationale behind this decision, especially considering the positive impact of FDA approval on the company's prospects.

Capital Raise Partner Selection: The selection of a capital raise partner with close ties to a major UBI shareholder and a director with a significant holding in UBI requires careful scrutiny. This potential conflict of interest necessitates transparency regarding the selection process and justification for the chosen partner.

Communication and Transparency: A lack of transparency regarding the nature and timing of recent discussions with the FDA, as well as the absence of a clear record date for the capital raise, are concerning. Timely and clear communication with shareholders is essential for informed decision-making.

These concerns highlight the critical importance of management actions that demonstrably prioritize long-term shareholder value. Shareholders have a right to expect clear communication and a compelling rationale behind decisions, especially those that may have a significant dilutive effect.

To better serve shareholder value, the capital raise could have been done at a premium to institution investors as they already received FDA approval, cancel capital raise 20c free option attachment as it fix a low ball options for no reason as FDA approval is already obtained, allow all shareholder to vote on decision making process not just that bought on or before 14th March.

Expand

Your little tiny stake in this company means nothing to them. You did nothing to help get this product to FDA approval. They owe you nothing. Once you understand this, investing is much more easier. Just be happy you have a ticket for the ride.

UBI Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

There are more pages in this discussion • 10 more messages in this thread...

First 16 Last

Add UBI (ASX) to my watchlist

(20min delay)
Last 15.0¢		Change 0.000(0.00%)		Mkt cap ! $44.71M

Open	High	Low	Value	Volume
15.0¢	15.5¢	15.0¢	$37.83K	252.0K

Buyers (Bids)

No.	Vol.	Price($)
1	20000	15.0¢

Sellers (Offers)

Price($)	Vol.	No.
15.5¢	54735	2

View Market Depth

No.	Vol.	Price($)
1	20000	0.150
3	170000	0.140
3	161591	0.135
4	40922	0.130
1	4100	0.125

Price($)	Vol.	No.
0.155	54735	2
0.160	104734	4
0.165	22000	1
0.170	600	1
0.180	16593	2

Last trade - 13.59pm 11/07/2024 (20 minute delay)

UBI (ASX) Chart

Ann: Notice of Meeting of Stockholders on 10 April 2024, page-16

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Canadian fieldwork yields multiple pegmatites for Trinex

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Notice of Meeting of Stockholders on 10 April 2024, page-16

Top Stories

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Canadian fieldwork yields multiple pegmatites for Trinex

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News